View More Recent Stories
-
Amgen (AMGN) Declares $2.25 Quarterly Dividend; 2.7% Yield
-
RBC's biotech survey shows investors more bearish vs. last time
-
10 policies if Trump wins and stock implications: Jefferies
-
Deutsche Bank Reiterates Hold Rating on Amgen (AMGN)
-
Amgen (AMGN) PT Raised to $337 at UBS
-
2Q24 U.S. biotech earnings preview
-
Jefferies Reiterates Buy Rating on Amgen (AMGN)
-
Amgen (AMGN) option implied volatility flat
-
Amgen (AMGN) PT Raised to $340 at Argus
-
Amgen (AMGN) PT Raised to $332 at RBC Capital

